-
s Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer
- Source: Current Pharmaceutical Biotechnology, Volume 23, Issue 15, Dec 2022, p. 1788 - 1791
-
- 01 Dec 2022
Preview this article:
Capecitabine as a Second-line Treatment for Older Patients with Pancreatic Cancer, Page 1 of 1
< Previous page Next page > /docserver/preview/fulltext/cpb/23/15/s4-1.gifThere is no abstract available.
© Bentham Science Publishers